From: Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients
Factors | Number (%) | AIFM3 expression | χ2 | P | Crude OR (95 CI) | |
---|---|---|---|---|---|---|
High (%) | Low (%) | |||||
Age(years) | 1.254 | 0.740a | ||||
≤ 40 | 26(17.2) | 14(53.8) | 12(46.2) | 0.318b | 0.583(0.203-1.680) | |
41-50 | 52(34.4) | 34(65.4) | 18(34.6) | 0.903b | 0.944(0.376-2.375) | |
51-60 | 40(26.5) | 25(62.5) | 15(37.5) | 0.712b | 0.833(0.317-2.190) | |
≥61 | 33(21.9) | 22(66.7) | 11(33.3) | Reference | ||
Tumor size | 6.135 | 0.013a | ||||
≥ 3 cm | 87(57.6) | 62(71.3) | 25(28.7) | 0.014b | 2.330(1.186-4.577) | |
< 3 cm | 64(42.4) | 33(51.6) | 31(48.4) | Reference | ||
LN Metastases | 11.824 | 0.001a | ||||
negative | 86(57.0) | 44(51.2) | 42(48.8) | Reference | ||
positive | 65(43.0) | 51(78.5) | 14(21.5) | 0.001b | 3.477(1.681-7.194) | |
ER | 0.266 | 0.606a | ||||
negative | 58(38.4) | 35(60.3) | 23(39.7) | Reference | ||
positive | 93(61.6) | 60(64.5) | 33(35.5) | 0.606b | 1.195(0.608-2.349) | |
PR | 1.160 | 0.281a | ||||
negative | 59(39.1) | 34(57.6) | 25(42.4) | Reference | ||
positive | 92(60.9) | 61(66.3) | 31(33.7) | 0.282b | 1.447(0.738-2.837) | |
Ki67 | 1.051 | 0.305a | ||||
negative | 62(41.1) | 42(67.7) | 20(32.3) | Reference | ||
positive | 89(58.9) | 53(59.6) | 36(40.4) | 0.306b | 0.701(0.355-1.384) | |
Her2 | 2.645 | 0.104a | ||||
negative | 101(66.9) | 59(58.4) | 42(42.6) | Reference | ||
positive | 50(33.1) | 36(72.0) | 14(28.0) | 0.106b | 1.831(0.879-3.811) | |
Histological grade | 1.902 | 0.398a | ||||
2 | 124(82.1) | 81(65.3) | 43(34.7) | Reference | ||
3 | 14(9.3) | 7(50.0) | 7(50.0) | 0.264b | 0.531(0.175-1.612) | |
unrated | 13(8.6) | 7(53.8) | 6(46.2) | 0.415b | 0.619(0.196-1.959) | |
Molecular typing | 7.935 | 0.047a | ||||
Luminal A | 60(39.7) | 41(68.3) | 19(31.7) | 0.011b | 3.596(1.337-9.673) | |
Luminal B | 48(31.8) | 32(66.7) | 16(33.3) | 0.021b | 3.333(1.200-9.256) | |
Her-2 | 19(12.6) | 13(68.4) | 6(31.6) | 0.048b | 3.611(1.012-12.888) | |
TNBC | 24(15.9) | 9(37.5) | 15(62.5) | Reference | ||
TNM staging | 17.197 | <0.001a | ||||
I | 38(25.2) | 14(36.8) | 24(63.2) | Reference | ||
II | 75(49.6) | 50(50.0) | 25(50.0) | 0.003b | 3.429(1.517-7.749) | |
III | 38(25.2) | 31(81.6) | 7(18.4) | <0.001b | 7.592(2.651-21.743) |